On August 22, 2014, the Drug Enforcement Administration (DEA) published a final rule upscheduling hydrocodone combination products (HCPs) under the Controlled Substances Act (CSA) from Schedule III to Schedule II.
The entities and individuals who handle or prescribe HCPs have only 45 days—until October 6, 2014—to come into full compliance with the increased regulatory controls that apply to Schedule II substances.
Please see full publication below for more information.